Loading...
XKRX
010600
Market cap33mUSD
Apr 05, Last price  
545.00KRW
Name

WellBiotec Co Ltd

Chart & Performance

D1W1MN
XKRX:010600 chart
P/E
—
P/S
0.59
EPS
—
Div Yield, %
—
Shrs. gr., 5y
13.74%
Rev. gr., 5y
-0.12%
Revenues
83.30b
+15.48%
112,671,917,00098,179,133,00073,916,511,00086,836,584,000119,782,624,540136,748,152,860137,762,428,120119,630,043,690112,488,077,21085,292,458,50070,785,770,56073,932,352,31083,816,105,78060,431,404,730121,623,324,840190,937,399,35072,132,464,14083,301,323,000
Net income
-21.22b
L-67.31%
-6,424,073,000-27,664,399,000-10,708,758,000-12,846,928,0001,581,589,420-2,946,007,0002,373,558,000-6,655,133,400550,244,150-2,450,152,000-8,742,014,280-15,565,917,620-16,552,641,460-50,907,598,070-21,213,649,860-6,418,574,850-64,910,322,280-21,219,761,000
CFO
-6.08b
L+45.78%
-891,690,0003,109,325,000-2,044,471,0002,903,495,000-246,005,3503,058,896,6901,010,203,010-1,534,357,9704,277,476,170-2,365,591,060-4,018,127,150-9,274,913,070-7,727,487,400-5,704,812,820712,970,1202,623,413,840-4,168,140,350-6,076,501,000
Dividend
Dec 28, 2005123.57275 KRW/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Wellbiotec Co., Ltd. produces and sells leather products in South Korea and internationally. The company provides leather products for shoes, bags, car seats, and handle covers. It also offers logistics consulting, container, warehouse/clearance, and transportation agency services; product research and development, consulting, distribution, and sales; and general and specialized medicines, health functional products, diagnosis kits, cosmeceuticals, and other products. In addition, the company is involved in casting agency, celebrity development, content production, and multi-channel network; and food and beverages businesses. The company was founded in 1975 and is headquartered in Seoul, South Korea.
URL
http://www.wellbiotec.co.kr/
IPO date
Jul 18, 1997
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT